Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000274934 encodes a non-coding RNA classified as “SMAD5 antisense RNA 1 conserved region 4.” This RNA is annotated as a miscellaneous RNA (misc_RNA), specifically an antisense transcript related to the SMAD5 locus[5][7]. There is currently no evidence that it encodes a protein, functions as a receptor, enzyme, or other classic therapeutic target, or is involved in established disease pathways. It is not listed as a target for drug interaction or biomarker use. This entry is not a canonical drug target, and the query likely refers to a locus without evidence for therapeutic targeting or druggability. The correct full name and relevant annotation is "SMAD5 antisense RNA 1 conserved region 4 (SMAD5-AS1_4)"[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SMAD5 antisense RNA 1 conserved region 4 (SMAD5-AS1_4).